June Xu
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
-
- Pancreatic function and diabetes
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 6
-
- Receptor Mechanisms and Signaling 4
- Metabolism, Diabetes, and Cancer 3
- Co-authors
- Keith T. Demarest (6 shared papers)Fuyong Du (4 shared papers)Yin Liang (4 shared papers)David Polidori (1 shared paper)Kirk Ways (1 shared paper)Yasuaki Matsushita (1 shared paper)Barbara R. Conway (1 shared paper)Yi Liu (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (6 papers)Journal of Clinical Oncology (5 papers)Frontiers in Endocrinology (1 paper)Bioorganic & Medicinal Chemistry (1 paper)Translational Lung Cancer Research (1 paper)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
June Xu
18 papers receiving 378 citations
Peers
Comparison fields: 5 of 59
- Endocrinology, Diabetes and Metabolism 211
- Surgery 170
- Oncology 83
- Molecular Biology 172
- Nephrology 17
Countries citing papers authored by June Xu
This map shows the geographic impact of June Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by June Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites June Xu more than expected).
Fields of papers citing papers by June Xu
This network shows the impact of papers produced by June Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by June Xu. The network helps show where June Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside June Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 200 | |
| 2 | 2018 | 29 | |
| 3 | 2007 | 22 | |
| 4 | 2007 | 21 | |
| 5 | 2020 | 19 | |
| 6 | 2019 | 14 | |
| 7 | 2020 | 13 | |
| 8 | 2018 | 11 | |
| 9 | 2020 | 10 | |
| 10 | 2021 | 9 | |
| 11 | 2021 | 8 | |
| 12 | 2018 | 7 | |
| 13 | 2020 | 7 | |
| 14 | 2021 | 6 | |
| 15 | 2020 | 4 | |
| 16 | 2021 | 4 | |
| 17 | 2020 | 3 | |
| 18 | 2023 | 2 | |
| 19 | 2024 | 0 |
About June Xu
June Xu is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Radiology, Nuclear Medicine and Imaging, having authored 19 papers that have together received 389 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Receptor Mechanisms and Signaling (4 papers), Pancreatic function and diabetes (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Advanced Breast Cancer Therapies (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (211 citations), Surgery (170 citations), Oncology (83 citations), Molecular Biology (172 citations) and Nephrology (17 citations). June Xu has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Keith T. Demarest, Fuyong Du, Yin Liang, David Polidori, Kirk Ways, Yasuaki Matsushita, Barbara R. Conway, Yi Liu, Kenji Arakawa and Tonya Martin. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Clinical Oncology, Frontiers in Endocrinology, Bioorganic & Medicinal Chemistry and Translational Lung Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.